307 related articles for article (PubMed ID: 22872171)
1. Vascular cognitive impairment and Alzheimer's disease: role of cerebral hypoperfusion and oxidative stress.
Kim HA; Miller AA; Drummond GR; Thrift AG; Arumugam TV; Phan TG; Srikanth VK; Sobey CG
Naunyn Schmiedebergs Arch Pharmacol; 2012 Oct; 385(10):953-9. PubMed ID: 22872171
[TBL] [Abstract][Full Text] [Related]
2. Cerebral hypoperfusion and cognitive impairment: the pathogenic role of vascular oxidative stress.
Liu H; Zhang J
Int J Neurosci; 2012 Sep; 122(9):494-9. PubMed ID: 22519891
[TBL] [Abstract][Full Text] [Related]
3. Chronic cerebral hypoperfusion: a key mechanism leading to vascular cognitive impairment and dementia. Closing the translational gap between rodent models and human vascular cognitive impairment and dementia.
Duncombe J; Kitamura A; Hase Y; Ihara M; Kalaria RN; Horsburgh K
Clin Sci (Lond); 2017 Oct; 131(19):2451-2468. PubMed ID: 28963120
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of brain damage and cognitive impairment by direct renin inhibition in mice with chronic cerebral hypoperfusion.
Dong YF; Kataoka K; Toyama K; Sueta D; Koibuchi N; Yamamoto E; Yata K; Tomimoto H; Ogawa H; Kim-Mitsuyama S
Hypertension; 2011 Oct; 58(4):635-42. PubMed ID: 21859961
[TBL] [Abstract][Full Text] [Related]
5. A Mini-Review of the NADPH oxidases in Vascular Dementia: Correlation with NOXs and Risk Factors for VaD.
Choi DH; Lee J
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165383
[TBL] [Abstract][Full Text] [Related]
6. Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-beta.
Park L; Wang G; Zhou P; Zhou J; Pitstick R; Previti ML; Younkin L; Younkin SG; Van Nostrand WE; Cho S; Anrather J; Carlson GA; Iadecola C
Proc Natl Acad Sci U S A; 2011 Mar; 108(12):5063-8. PubMed ID: 21383152
[TBL] [Abstract][Full Text] [Related]
7. Neuronal damage, central cholinergic dysfunction and oxidative damage correlate with cognitive deficits in rats with chronic cerebral hypoperfusion.
Xi Y; Wang M; Zhang W; Bai M; Du Y; Zhang Z; Li Z; Miao J
Neurobiol Learn Mem; 2014 Mar; 109():7-19. PubMed ID: 24315928
[TBL] [Abstract][Full Text] [Related]
8. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
Bell RD; Zlokovic BV
Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Pathological Benefit of Twendee X in Alzheimer's Disease Transgenic Mice with Chronic Cerebral Hypoperfusion.
Liu X; Yamashita T; Shang J; Shi X; Morihara R; Huang Y; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1993-2002. PubMed ID: 31029568
[TBL] [Abstract][Full Text] [Related]
10. Cerebrovascular damage as a cause for Alzheimer's disease.
Humpel C; Marksteiner J
Curr Neurovasc Res; 2005 Oct; 2(4):341-7. PubMed ID: 16181125
[TBL] [Abstract][Full Text] [Related]
11. Carotid artery ultrasound and echocardiography testing to lower the prevalence of Alzheimer's disease.
de la Torre JC
J Stroke Cerebrovasc Dis; 2009; 18(4):319-28. PubMed ID: 19560690
[TBL] [Abstract][Full Text] [Related]
12. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
Daulatzai MA
J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
[TBL] [Abstract][Full Text] [Related]
13. Transient Mild Cerebral Ischemia Significantly Deteriorated Cognitive Impairment in a Mouse Model of Alzheimer's Disease via Angiotensin AT1 Receptor.
Nakagawa T; Hasegawa Y; Uekawa K; Senju S; Nakagata N; Matsui K; Kim-Mitsuyama S
Am J Hypertens; 2017 Feb; 30(2):141-150. PubMed ID: 27572961
[TBL] [Abstract][Full Text] [Related]
14. Acupuncture elicits neuroprotective effect by inhibiting NAPDH oxidase-mediated reactive oxygen species production in cerebral ischaemia.
Shi GX; Wang XR; Yan CQ; He T; Yang JW; Zeng XH; Xu Q; Zhu W; Du SQ; Liu CZ
Sci Rep; 2015 Dec; 5():17981. PubMed ID: 26656460
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin receptor blocker prevented beta-amyloid-induced cognitive impairment associated with recovery of neurovascular coupling.
Takeda S; Sato N; Takeuchi D; Kurinami H; Shinohara M; Niisato K; Kano M; Ogihara T; Rakugi H; Morishita R
Hypertension; 2009 Dec; 54(6):1345-52. PubMed ID: 19805638
[TBL] [Abstract][Full Text] [Related]
16. The concept of vascular cognitive impairment.
Erkinjuntti T; Gauthier S
Front Neurol Neurosci; 2009; 24():79-85. PubMed ID: 19182465
[TBL] [Abstract][Full Text] [Related]
17. Role of Rac1 GTPase in NADPH oxidase activation and cognitive impairment following cerebral ischemia in the rat.
Raz L; Zhang QG; Zhou CF; Han D; Gulati P; Yang LC; Yang F; Wang RM; Brann DW
PLoS One; 2010 Sep; 5(9):e12606. PubMed ID: 20830300
[TBL] [Abstract][Full Text] [Related]
18. Carotid artery stenosis in hypertensive rats impairs dilatory pathways in parenchymal arterioles.
Matin N; Fisher C; Jackson WF; Diaz-Otero JM; Dorrance AM
Am J Physiol Heart Circ Physiol; 2018 Jan; 314(1):H122-H130. PubMed ID: 28842441
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
[TBL] [Abstract][Full Text] [Related]
20. NADPH oxidases: novel therapeutic targets for neurodegenerative diseases.
Gao HM; Zhou H; Hong JS
Trends Pharmacol Sci; 2012 Jun; 33(6):295-303. PubMed ID: 22503440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
